当前位置: 首页 > 期刊 > 《中国医学创新》 > 2025年第12期
编号:2316511
华蟾素胶囊联合富马酸替诺福韦二吡呋酯对肝癌患者肝功能的改善效果
http://www.100md.com 2025年6月5日 中国医学创新 2025年第12期
     Improvement Effect of Huachansu Capsules Combined with Tenofovir Disoproxil Fumarate on Liver Function in Patients with Liver Cancer/ZHU Huiting, LI Menglin, WU Feiyuan.//Medical Innovation of China,2025,22(12): 069-073

    [Abstract]Objective: To explore the efect of Huachansu Capsules combined with Tenofovir Disoproxil Fumarate on patients with liver cancer.Method: A total of 84 patients with liver cancer admitted to Pingxiang Second People's Hospital from January 2021 to January 2024 were selected and divided into two groups according to random number table method, with 42 patients in each group.The control group was treated with Tenofovir Disoproxil Fumarate,and theobservation groupwas treatedwithHuachansu Capsules on the basis ofthe control group.The clinical effcacy,hepatitisBvirus gene (HBV-DNA),liver function indexesalanine aminotransferase (ALT),aspartate aminotransferase (AST),glutamyltransferase (GGT)] and the occurrence of adverse reactions between thetwo groups were compared. Result: The total efective rate of the observation group was higherthan that of the control group ( P lt;0.05). After treatment ......

您现在查看是摘要页,全文长 12423 字符